News: RHY Rhythm Biosciences Files With TGA To List Colostat On Register Of Therapeutic Goods, page-38

One of the biggest hurdles that RHY is going to have to overcome is the lobbying from the companies that supply the FOBT because, regardless of how useless their product is, they dont want their profits to evaporate.
The report seems to suggest that the FOBT is still by far the best option for detecting bowel cancer and that other therapies still have a long way to go to prove themselves. They are either too expensive or that there is insufficient data currently to consider them - all which is a load of CRAP!

It really does amaze me the lengths that corporate scum will go to, even if it directly endangers peoples lives, to keep the money rolling in.

With any luck we no longer have a Govt in control that will succumb quite as easily and might actually do the right thing.